# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

Liver cancer

Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 1-10 of 699 results.
Primary Liver Cancer Cohort of South China
Status: Recruiting
Last Changed: Sep 29, 2017
First Received: Sep 29, 2017
Disease(s): Primary Liver Cancer
Locations: Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China
Study of Activated Cytokine-induced Killer Armed With Bispecific Antibody for Advanced Liver Cancer
Status: Recruiting
Last Changed: Sep 12, 2019
First Received: Apr 02, 2018
Disease(s): Advanced Liver Cancer
Intervention(s): Activated CIK and CD3-MUC1 Bispecific Antibody in Treating Liver Cancer, cryotherapy
Locations: Biological treatment center in Fuda cancer hospital, Guangzhou, Guangdong, China
Institutional Review Board of Guangzhou Fuda Cancer Hospital, Guangzhou, Guangdong, China
Study of Activated CIK Armed With Bispecific Antibody for Advanced Liver Cancer
Status: Recruiting
Last Changed: Sep 02, 2019
First Received: May 10, 2017
Disease(s): Advanced Liver Cancer
Intervention(s): Activated CIK and bispecific antibody, Activated CIK
Locations: 302 Military Hospital of China, Beijing, Beijing, China
Clinical Trial of Cinobufacini Combined With Transarterial Chemoembolization (TACE) on Primary Liver Cancer
Status: Recruiting
Last Changed: Feb 18, 2019
First Received: Feb 18, 2019
Disease(s): Liver Cancer
Intervention(s): Cinobufacini injection, Transarterial Chemoembolization(TACE), cinobufacini tablet
Locations: The First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning, China
Dynamic Contrast Enhanced Computed Tomography to Assess Radiation Therapy in Liver Cancer Patients
Status: Not yet recruiting
Last Changed: Jun 24, 2019
First Received: Mar 27, 2019
Disease(s): Liver Cancer
Intervention(s): Dynamic Contrast Enhanced Computed Tomography
Locations: University of Colorado Denver, Aurora, Colorado, United States
Pharmacokinetics of Doxorubicin in cTACE of Liver Cancer
Status: Recruiting
Last Changed: Feb 26, 2018
First Received: Apr 28, 2016
Disease(s): Liver Cancer
Intervention(s): whole liver lobe cTACE doxorubicin, superselective cTACE doxorubicin
Locations: Yale University, Department of Diagnostic Radiology, New Haven, Connecticut, United States
Percutaneous Irreversible Electroportion in Unresectable Liver Cancer Close to Diaphragmatic Dome
Status: Recruiting
Last Changed: Sep 13, 2019
First Received: Dec 31, 2014
Disease(s): Liver Cancer
Intervention(s): Irreversible electroporation (IRE)
Locations: FUDA Cancer Hospital, Guangzhou, Guangdong, China
Clinical Trial of Elemene in Combination With Oxaliplatinin the Treatment of Advanced Primary Liver Cancer
Status: Recruiting
Last Changed: May 25, 2017
First Received: May 25, 2017
Disease(s): Advanced Primary Liver Cancer
Intervention(s): Elemene
Locations: 302 Military Hospital of China, Beijing, Beijing, China
The First Hospital of Lanzhou University, Lanzhou, Gansu, China
The First Hospital of Hebei Medical University, Shijiazhuang, Hebei, China
Harbin Medical University Cancer Hospital, Harbin, Heilongjiang, China
Henan Medical University Cancer Hospital, Zhengzhou, Henan, China
... and 6 other locations.
Clinical Trial of Elemene Injection/Elemene Oral Emulusion in Combination With the Best Supportive Treatment in the Treatment of Advanced Primary Liver Cancer
Status: Recruiting
Last Changed: May 30, 2017
First Received: May 30, 2017
Disease(s): Advanced Primary Liver Cancer
Intervention(s): Elemene Injection/Elemene Oral Emulusion
Locations: Henan Medical University Cancer Hospital, Zhengzhou, Henan, China
Study Evaluating the Efficacy and Safety With CAR-T for Liver Cancer
Status: Recruiting
Last Changed: Mar 15, 2017
First Received: Apr 06, 2016
Disease(s): Liver Neoplasms
Intervention(s): EPCAM-targeted CAR-T cells
Locations: Anhui No.2 Province People's Hospital, Hefei, Anhui, China